Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen (AMGN) Stock Down Despite Q2 Earnings & Sales Beat
10:56am, Wednesday, 07'th Aug 2024
Amgen (AMGN) beats second-quarter 2024 estimates for earnings and sales. It tightens its revenue and earnings guidance range for 2024.
Amgen's MariTide Weight Loss Potential: Stock Outlook
09:52am, Wednesday, 07'th Aug 2024
Amgen NASDAQ: AMGN is a biotechnology firm that has made its way into the weight loss treatment battle. The company's shares have performed relatively well in 2024, providing a total return of 16%, ou
Amgen Inc. (AMGN) Q2 2024 Earnings Call Transcript
10:18pm, Tuesday, 06'th Aug 2024
Amgen Inc. (NASDAQ:AMGN ) Q2 2024 Results Conference Call August 6, 2024 4:30 PM ET Company Participants Justin Claeys - Vice President of Investor Relations Bob Bradway - Chairman, CEO & President Mu
Amgen (AMGN) Reports Q2 Earnings: What Key Metrics Have to Say
07:00pm, Tuesday, 06'th Aug 2024
The headline numbers for Amgen (AMGN) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Amgen (AMGN) Q2 Earnings and Revenues Beat Estimates
06:16pm, Tuesday, 06'th Aug 2024
Amgen (AMGN) came out with quarterly earnings of $4.97 per share, beating the Zacks Consensus Estimate of $4.93 per share. This compares to earnings of $5 per share a year ago.
Amgen CFO talks Q2 earnings, obesity drug, and growth
05:48pm, Tuesday, 06'th Aug 2024
Amgen (AMGN) posted second quarter revenue of $8.4 billion, topping expectations of $8.34 billion. Sales rose by 20% in the quarter, however, the company noted that lower net selling prices partially
Amgen Is Redoubling Its Efforts To Take On Weight-Loss Kingpins Novo, Lilly
05:20pm, Tuesday, 06'th Aug 2024
Amgen stock fell late Tuesday after the biotech reported lighter-than-expected second-quarter profits, though sales beat.
Amgen second quarter profit dips, sales rise 20%
04:06pm, Tuesday, 06'th Aug 2024
Amgen on Tuesday said its second-quarter profit slipped 1% as higher expenses offset a 20% increase in revenue driven by the biotechnology company's October acquisition of rare disease drugmaker Horiz
AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
04:01pm, Tuesday, 06'th Aug 2024
THOUSAND OAKS, Calif. , Aug. 6, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the second quarter 2024.
Amgen Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
11:42am, Tuesday, 06'th Aug 2024
Amgen Inc. AMGN is expected to release earnings results for its second quarter, after the closing bell on Tuesday, Aug. 6.
Investing in biotech outside of weight-loss drugs
06:19pm, Monday, 05'th Aug 2024
GLP-1 weight-loss drugs have pushed the biotech sector to new heights as demand steadily increases. But despite the drugs' popularity, there are other investment opportunities within the biotech secto
Dow Jones Biotech Amgen, MercadoLibre, Ferrari Hold Up In Shaken Market
01:51pm, Monday, 05'th Aug 2024
Dow Jones biotech giant Amgen, along with MercadoLibre, Ferrari and Lennar, are in or near buy zones in today's stock market sell-off.
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
12:41pm, Monday, 05'th Aug 2024
Let's look at five biotech and drug companies, AMGN, GILD, LLY, VTRS & NVO, due to release their second-quarter 2024 results this week.
AMGEN ANNOUNCES 2024 THIRD QUARTER DIVIDEND
04:00pm, Friday, 02'nd Aug 2024
THOUSAND OAKS, Calif. , Aug. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the third quarter of 2024.
3 Biotech Stocks That Could Have Investors Grinning Soon
01:54pm, Friday, 02'nd Aug 2024
Investing in biotech stocks is a thrilling ride. These innovative businesses developing breakthrough drugs can generate enormous profits for investors but also destroy significant value if their inves
